EJPB 11827
No. of Pages 9, Model 5G
16 February 2015
´
9
K. Kaminski et al. / European Journal of Pharmaceutics and Biopharmaceutics xxx (2015) xxx–xxx
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
for substrate reduction therapy in Sanfilippo disease and other
mucopolysaccharidoses, Metab. Brain Dis. 26 (2011) 1–8.
[36] V.J. Stella, Q. He, Cyclodextrins, Toxicol. Pathol. 36 (2008) 30–42.
[37] Y. Sun, A. Wan, Preparation of nanoparticles composed of chitosan and its
derivatives as delivery systems for macromolecules, J. Appl. Polym. Sci. 105
(2007) 552–561.
[22] S.V. Kurkov, T. Loftsson, Cyclodextrins, Int. J. Pharm. 453 (2013) 167–180.
[23] T. Loftsson, M.E. Brewster, Pharmaceutical applications of cyclodextrins: basic
science and product development, J. Pharm. Pharmacol. 62 (2010) 1607–1621.
[24] B. Lorkowska-Zawicka, K. Kamin´ ski, J. Ciejka, et al., Inactivation of heparin by
cationically modified chitosan, Mar. Drugs 12 (2014) 3953–3969.
[25] J. McCarthy, M.J. O’Neill, L. Bourre, et al., Gene silencing of TNF-alpha in a
murine model of acute colitis using a modified cyclodextrin delivery system, J.
Control. Release 168 (2013) 28–34.
[38] W. Tang, S.c. Ng, Facile synthesis of mono-6-amino-6-deoxy-a-, b-, c-
cyclodextrin hydrochlorides for molecular recognition, chiral separation and
drug delivery, Nat. Protoc. 3 (2008) 691–697.
[39] Z. Teng, Y. Li, Y. Niu, Y. Xu, L. Yu, Q. Wang, Cationic b-lactoglobulin
nanoparticles as
a
bioavailability enhancer: comparison between
ethylenediamine and polyethyleneimine as cationizers, Food Chem. 159
(2014) 333–342.
[26] S. Menuel, J.P. Joly, B. Courcot, J. Elysée, N.E. Ghermani, A. Marsura, Synthesis
and inclusion ability of
a
bis-b-cyclodextrin pseudo-cryptand towards
[40] T.R. Thatiparti, A.J. Shoffstall, H.A. Von Recum, Cyclodextrin-based device
coatings for affinity-based release of antibiotics, Biomaterials 31 (2010) 2335–
2347.
[41] D.C. Vitale, C. Piazza, B. Melilli, F. Drago, S. Salomone, Isoflavones: estrogenic
activity, biological effect and bioavailability, Eur. J. Drug Metab.
Pharmacokinet. 38 (2013) 15–25.
[42] B.D. Wagner, N. Stojanovic, G. Leclair, C.K. Jankowski, A spectroscopic and
molecular modelling study of the nature of the association complexes of Nile
Red with cyclodextrins, J. Incl. Phenom. Macrocycl. Chem. 45 (2003) 275–283.
[43] W.M. Wu, J. Wu, N. Bodor, Effect of 2-hydroxypropyl-beta-cyclodextrin on the
solubility, stability, and pharmacological activity of the chemical delivery
system of TRH analogs, Pharmazie 57 (2002) 130–134.
[44] Y. Xiao, L. Yang, P. Mao, J. Yuan, Y. Deng, L. Qu, Inclusion complexes of
phosphorylated daidzein derivatives with cyclodextrin: preparation and
inclusion behavior study, Spectrochim. Acta A 85 (2012) 298–302.
[45] K. Yannakopoulou, Cationic cyclodextrins: cell penetrating agents and other
diverse applications, J. Drug Deliv. Sci. Technol. 22 (2012) 243–249.
[46] M. Zaman, H. Liu, H. Xiao, F. Chibante, Y. Ni, Hydrophilic modification of
polyester fabric by applying nanocrystalline cellulose containing surface
finish, Carbohydr. Polym. 91 (2013) 560–567.
[47] M. Zhang, X. Wu, L. Zhang, Q. Zhu, S. Gao, Progress of modified polycationic
vectors in gene therapy, Pharm. Care Res. 13 (2013) 25–29.
[48] J. Zhou, F. Ai, B. Zhou, J. Tang, S.C. Ng, W. Tang, Hydroxyethylammonium
monosubstituted cyclodextrin as chiral selector for capillary electrophoresis,
Anal. Chim. Acta 800 (2013) 95–102.
[49] Y. Zhou, B. Yang, X. Ren, et al., Hyperbranched cationic amylopectin derivatives
for gene delivery, Biomaterials 33 (2012) 4731–4740.
[50] Q.F. Zhang, W.J. Yi, B. Wang, et al., Linear polycations by ring-opening
polymerization as non-viral gene delivery vectors, Biomaterials 34 (2013)
5391–5401.
Busulfan anticancer agent, Tetrahedron 63 (2007) 1706–1714.
´
[27] A. Mielanczyk, M. Skonieczna, K. Bernaczek, D. Neugebauer, Fluorescein
nanocarriers based on cationic star copolymers with acetal linked sugar cores.
Synthesis and biochemical characterization, RSC Adv. 4 (2014) 31904–31913.
[28] N. Niyomtham, N. Apiratikul, K. Chanchang, P. Opanasopit, B.E.
Yingyongnarongkul, Synergistic effect of cationic lipids with different
polarheads, central core structures and hydrophobic tails on gene
transfection efficiency, Biol. Pharm. Bull. 37 (2014) 1534–1542.
[29] B. Pahari, B. Sengupta, S. Chakraborty, B. Thomas, D. McGowan, P.K. Sengupta,
Contrasting binding of fisetin and daidzein in
Photochem. Photobiol., B 118 (2013) 33–41.
c-cyclodextrin nanocavity, J.
[30] N. Pahimanolis, A. Salminen, P.A. Penttilä, et al., Nanofibrillated cellulose/
carboxymethyl cellulose composite with improved wet strength, Cellulose 20
(2013) 1459–1468.
[31] E. Piotrowska, J. Jakóbkiewicz-Banecka, S. Baran, A. Tylki-Szyman´ ska, B.
Czartoryska, A. We˛grzyn, G. We˛grzyn, Genistein-mediated inhibition of
glycosaminoglycan synthesis as
a basis for gene expression-targeted
isoflavone therapy for mucopolysaccharidoses, Eur. J. Human Genet. 14
(2006) 846–852.
[32] L.Y. Qiu, R.J. Wang, C. Zheng, Y. Jin, Q. Jin le, Beta-cyclodextrin-centered star-
shaped amphiphilic polymers for doxorubicin delivery, Nanomedicine
(London) 5 (2010) 193–208.
[33] K.P. Sambasevam, S. Mohamad, N.M. Sarih, N.A. Ismail, Synthesis and
characterization of the inclusion complex of b-cyclodextrin and azomethine,
Int. J. Mol. Sci. 14 (2013) 3671–3682.
[34] A. Sowmya, S. Meenakshi,
A novel quaternized resin with acrylonitrile/
divinylbenzene/vinylbenzyl chloride skeleton for the removal of nitrate and
phosphate, Chem. Eng. J. 257 (2014) 45–55.
[35] J. Stefan, B. Lorkowska-Zawicka, K. Kaminski, K. Szczubialka, M. Nowakowska,
R. Korbut, The current view on biological potency of cationically modified
chitosan, J. Physiol. Pharmacol. 65 (2014) 341–347.
773
Please cite this article in press as: K. Kamin´ ski et al., Enhanced delivery of daidzein into fibroblasts and neuronal cells with cationic derivatives of gamma-